Bacitracin Ophthalmic Ointment Shortage: Supply Issues Reported Due to Manufacturing Discontinuation
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bacitracin Ophthalmic Ointment is currently unavailable from major suppliers due to manufacturing discontinuation, with shortages expected to persist for up to 20 months.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Bacitracin.
What's in Shortage
Bacitracin Ophthalmic Ointment (Brand Name: BACITRACIN) is currently listed in a shortage status. This medication is classified under the therapeutic categories of Anti-Infective and Ophthalmology and is administered as an ophthalmic ointment.
Which Manufacturers Are Affected
The following manufacturer is currently impacted:
- Padagis US LLC
- Status: Unavailable
- Presentation: Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
- Notes: The shortage for this product is estimated to last for approximately 20 months.
- Contact Information: 866-634-9120
Why There's a Shortage
The current shortage is attributed to the discontinuation of the manufacture of the drug.
What Patients Should Do
Patients who rely on Bacitracin Ophthalmic Ointment should take the following steps:
- Consult Your Healthcare Provider: Speak with your doctor or ophthalmologist to discuss the shortage and determine the best course of action for your specific medical needs.
- Talk to Your Pharmacist: Your pharmacist can provide information on current local availability or help coordinate with your physician regarding alternatives.
- Contact the Manufacturer: For specific questions regarding supply timelines, you may contact Padagis US LLC at the number provided above.
Disclaimer: This article is for informational purposes only. Patients should always consult their healthcare provider for medical advice, diagnosis, or treatment options regarding medication changes.
Source
Information provided by the FDA Drug Shortage Database.
- Initial Posting Date: 03/03/2025
- Last Updated: 02/04/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.